Monitoring new oral antithrombotics: what we should know before we can decide

被引：5
作者：
Al dieri, R. [1 ]
Hemker, H. C. [1 ]
机构：
[1] Cardiovasc Res Inst Maastricht, Synapse BV, NL-6200 MD Maastricht, Netherlands
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2010年 / 8卷 / 12期
关键词：
DIRECT THROMBIN INHIBITOR; HEALTHY MALE-SUBJECTS; POPULATION PHARMACOKINETICS; LABORATORY MONITORING; VENOUS THROMBOEMBOLISM; PHARMACODYNAMICS; GENERATION; HEPARIN; XIMELAGATRAN; HYPERCOAGULABILITY;
D O I：
10.1111/j.1538-7836.2010.04057.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2833 / 2835
页数：4
相关论文
共 50 条
[31]   What We Know (and Do not Know) Regarding the Pathogenesis of Pulmonary Thrombosis in COVID-19 [J].
Lippi, Giuseppe ;
Favaloro, Emmanuel J. .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2023, 49 (01) :27-33
[32]   Anticoagulants after Discharge in Patients with COVID-19: What we Know at the End of 2021 [J].
Yavelov, I. S. .
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2021, 17 (06) :908-915
[33]   Stemming the Hype: What Can We Learn from iPSC Models of Parkinson's Disease and How Can We Learn It? [J].
Jacobs, Benjamin Meir .
JOURNAL OF PARKINSONS DISEASE, 2014, 4 (01) :15-27
[34]   Incidental venous thromboembolic events in cancer patients: what we know in 2016 [J].
Liebman, Howard A. ;
O'Connell, Casey .
THROMBOSIS RESEARCH, 2016, 140 :S18-S20
[35]   Pharmacogenetics to prevent heparin-induced thrombocytopenia: what do we know? [J].
Karnes, Jason H. .
PHARMACOGENOMICS, 2018, 19 (18) :1413-1422
[36]   What Do We Know about Peripartum Cardiomyopathy? Yesterday, Today, Tomorrow [J].
Lasica, Ratko ;
Asanin, Milika ;
Vukmirovic, Jovanka ;
Maslac, Lidija ;
Savic, Lidija ;
Zdravkovic, Marija ;
Simeunovic, Dejan ;
Polovina, Marija ;
Milosevic, Aleksandra ;
Matic, Dragan ;
Juricic, Stefan ;
Jankovic, Milica ;
Marinkovic, Milan ;
Djukanovic, Lazar .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (19)
[37]   Checkpoint Inhibitors, CAR T Cells, and the Hemostatic System: What Do We Know So Far? [J].
Rolling, Christina C. ;
Lewirt, Samuel ;
Beitzen-Heineke, Antonia ;
Beckmann, Lennart ;
Bokemeyer, Carsten ;
Alsdorf, Winfried ;
Voigtlaender, Minna ;
Langer, Florian .
HAMOSTASEOLOGIE, 2025, 45 (02) :175-187
[38]   Pregnancy in sickle cell trait: what we do and don't know [J].
Wilson, Samuel ;
Ellsworth, Patrick ;
Key, Nigel S. .
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (03) :328-335
[39]   Pharmacokinetic and pharmacodynamic alterations in older people: what we know so far [J].
Mangoni, Arduino A. ;
Woodman, Richard J. ;
Jarmuzewska, Elzbieta A. .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2025, 21 (07) :811-829
[40]   Therapeutic drug monitoring guidelines in oncology: what do we know and how to move forward? Insights from a systematic review [J].
Li, Xinya ;
Song, Zaiwei ;
Yi, Zhanmiao ;
Qin, Jiguang ;
Jiang, Dan ;
Wang, Zhitong ;
Li, Huibo ;
Zhao, Rongsheng .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
12345